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ABSTRACT 
Memory is the retention power of information in the brain. of Brassica oleracea commonly called ‘Broccoli’ has been known for its anti-
inflammatory action. In this investigation, memory enhancing activity of Brassica oleracea is to be undertaken.  Two doses of the drug Brassica 
oleracea extract (100 mg/kg and 200 mg/kg p.o) were selected after acute toxicity studies were subjected for the evaluation of cognition and 
memory enhancing paradigm against scopolamine (0.4mg/kg, i.p) induced amnesic albino rats. Piracetam (120 mg/kg i.p) served as standard 
drug for both the models (Elevated T maze, Passive avoidance test) undergoing investigation. Brain Anticholinesterase activity was observed as 
biochemical parameter for estimation. Both dose (100 mg/kg & 200mg/kg) of Brassica oleracea extract has shown dose dependent notable 
decrement in Transfer latency (TL) by EPM, reduced Anti Cholinesterase activity in brain signifies improved learning when compared to the 
test scopolamine group. Sub-acute long term treatment was found to be more significant than acute i.e. short term treatment on cognition and 
memory enhancing activity. 
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INTRODUCTION 
Alzheimer’s disease, one of the most common disease of 
dementia, is a progressive, gradual neurodegenerative 
disease which is slow in onset which eventually, results in 
dementia, uncommon behavior, personality change and, 
finally leads to death. Creation of memory is the most 
complex process involving multiple neural pathways and 
neurotransmitters. It has been found out that the cholinergic 
nervous system plays a crucial role in learning and memory 
in humans and animals. [1] 
Despite the great efforts and researches that have been 
made in understanding the disease and in management of 
these neurodegenerative diseases such as Alzheimer’s 
disease (AD) but disease related complications are 
increasing unabatedly. A variety of synthetic drug therapies 
are available for the treatment of Alzheimer but they 
associated with severe side effects and are expensive. 
Therefore, it has become priority to explore all the available 
approaches to address the menace of this disease for 
controlling it. Alternative herbal approaches containing 
plant medication and herbal formulations are found of to be 
less toxic, with least side effects than synthetic one. Several 
plants such as Azadirachta indica,[2] Bacopa monniera,[3] 
Withania somnifera,[4] as well as Ocimum sanctum,[5] are  
found to be very effective In spite of using synthetic 
medicines, herbal plants can be used to treat these disease 
with success. 
Brassica oleracea commonly called ‘Broccoli‘ belonging to 
genus Brassica is a vegetable known for its non-enzymatic 
bioactive compounds such as poly phenols, flavanoids, 
carotenoids, anthocyanin making it highly antioxidant in 
diet. This helps in reducing oxidative stress and is thus 
investigated in present study for its memory enhancing 
activity. [6] 
 
Figure 1- Broccoli florets 
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MATERIAL AND METHODS  
Animals:  Sprang Dawley male albino rats weighing 150-
180g were employed for study. They have ad. libitum access 
to water food pellets (Hindustan Lever Ltd., Mumbai) 
maintaining the standard controlled room temperature 
(24±2°C) with alternating 12-h light-dark cycle in groups of 
three to four per cage. The experiment was carried out in a 
quite environment between 8.00 and 12.00 am. Approval 
was granted from the Institutional Animal Ethics Committee, 
Modern Institute of Pharmaceutical Sciences, Indore, India 
for conducting the study. 
Acute toxicity study: The acute toxicity was performed as 
specified in   OECD 423 guidelines. [7] The extract 
suspension, at the dose of 5,50,100, 300 and 2000 mg/kg 
body weight, was dispensed orally to the rats and were 
subsequently observed closely for the first 4 h for any 
unusual behavioral symptoms such as salivation, tremors, 
exophthalmus, convulsions, lethargy & diarrhea followed by 
observation for a further 14 days, the animals were 
observed for any changes in behavioral pattern and 
mortality.  One tenth of the safe dose was selected for the 
study. 
Chemicals: Scopolamine, Acetylcholine(Sigma Laboratories, 
Mumbai, Maharashtra, India), Piracetam (UCB India Ltd., 
Mumbai, Maharashtra, India), simvastatin (Krebs 
Biochemicals and Industries Limited, Hyderabad, India. 
Drugs administration: Brassica oleracea purchased from 
the local market of Indore and were authenticated at the 
Government Agriculture College, Indore, India. Floret were 
separated and were dried under shade and hydroalcoholic 
(70:30) extract was prepared under soxhlet assembly for 48 
hours. Then, the extract was dispensed orally to the rats at 
two doses of 100 and 200 mg/kg/day daily at the same time 
suspended in 1% CMC solution. 
Laboratory Models for Testing Learning and Memory 
(i) Elevated plus-maze. 
(ii) Passive shock avoidance paradigm. 
(iii) Biochemical estimation 
Experimental protocol: the rats were trained daily at same 
time for 15 days then the rats were divided into two sets 
containing eight groups each (16 groups) with treatment 
period of 7 day and 14 days respectively. Except for the 
vehicle control group, all the animals were given 
scopolamine on 7th and 14th day after 1 hour of drug 
administration. After its 45 minutes, cognitive parameters 
were analyzed using EPM, and passive avoidance. This trail 
conducted is called as Acquisition Trial (AT), which 
corresponds to learning. Again after 24 hr the same 
procedure is followed using models EPM, passive avoidance 
test which will be termed as Retention Trial (RT) which 
corresponds to retention of learning or memory. Further, for 
biochemical estimation the rats were euthanized by cervical 
decapitation and their brains were isolated to evaluate the 
anticholinesterase (ChE) activity of Brassica oleracea. [8] 
Exteroceptive behavioral models  
EPM: The EPM[9,10] used to evaluate anxiety & cognition  ,is a 
elevated maze at height 50 cm above ground, it has  two 
open (50 cm × 10 cm × 40 cm) ,two enclosed arms (50 cm × 
10 cm × 40 cm),and an open roof, arranged in a manner that 
the open arms were opposite each other. 
On the 7th  and 14th  days, respectively to analyze the 
learning and memory retained, each rat was placed at the 
end of an open arm, in the opposite direction to the central 
platform, the time taken by rat to move and enter in the 
other closed arm is termed as Transfer latency (TL)  is 
recorded. If the rat did not enter in other closed arm in 180 
seconds, they are pushed  into one of the two closed arms 
and in this case TL was assigned to 180 s. The rats was 
allowed to move in  the maze for 15 seconds and then are 
returned to their cage. After 24 hours to calculate RT or 
memory retained again TL is analyzed on 8th and 15th day. 
Passive shock avoidance paradigm: Passive avoidance, [9, 
10] I a fear aggravated test used to evaluate long term 
memory . The apparatus is box (27 cm x 27 cm x 27 cm) 
having three wooden walls and a plexiglass wall, with a grid 
floor (consisting of 3 mm stainless steel bars spaced 8 mm 
apart), with a platform (10 cm × 7 cm × 1.7 cm) in the middle 
of the grid floor. The box was lit with a 15 W bulb during the 
experimental period. The electric shock was applied to the 
floor of the box. The rats were initially trained in the 
following manner: each rat was placed on a wooden 
platform in the center of the floor of the grid. When the rat 
steps down and places the paw on the floor of the grid, a 
discharge was administered (foot discharge: 50 Hz, 1.5 mA, 1 
s) and the Step Down Latency (SDL) was recorded. SDL is 
defined as the time taken by rat to step  down to keep all 4 
paws on the grid floor. Rats showing SDL in the range of 2 to 
15 seconds during the training session were taken for 
acquisition and conservation activities. The acquisition 
operation was performed 90 minutes after the training 
session. During the acquisition test, the animals were 
removed from the area without discharge if they were not 
removed for a period of 60 s. Retention was tested after 24 
hours in a similar manner, except for a cut-off time of more 
than 180 s. 
Interoceptive behavioral models  
Estimation of ACh Levels in the Brain by Quantifying ChE 
Inhibition: 
After evaluating the learning and memory paradigms, the 
rats in each group were sacrificed by cervical decapitation. 
The entire brain was removed immediately and cooled in 
frozen phosphate buffer. After washing in cold phosphate 
buffer, the brains were homogenized in 5 ml of phosphate 
buffer in a TEFLON glass homogenizer. The enzymatic 
activity of the cerebral homogenate was then evaluated 
using the Augustinsson analysis method .[11] 
RESULTS 
Acute toxicity profile: Rats treated with Brassica oleracea 
extract, 5-2,000 mg / kg, p.o., showed normal behavior. They 
were alert, with a normal grooming, response to touch and 
response to pain. There were no signs of depression, 
stereotyping and vocalization. The alertness, the tone of the 
extremities and the strength of grip and the walking of the 
animals were normal. The brassica oleracea suspension was 
safe up to a dose of 2,000 mg / kg in rats. 
Exteroceptive behavioral models  
Elevated Plus Maze Model: On 7th and 14th day, at the end 
of treatment period, the effect of the vehicle, scopolamine 
control, Brassica oleracea (100 and 200 mg/kg) and 
Piracetam (120 mg/kg) were analyzed. The scopolamine 
control group (0.4 mg / kg) showed notable increase (P 
<0.01) in TL of acquisition and on retention as compared to 
vehicle control rats, indicating a impairment in learning and 
in memory. At AT on day 7 for set I and day 14 for set II  and 
At RT of day 8 for set I and day 15 for set II, Brassica oleracea 
at dose levels of 100 and 200 mg / kg showed a significant  
dose dependent decrease (P <0.01) in TL compared to 
control group scopolamine. Piracetam (120 mg/kg p.o.) 
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exhibited significant decrease (P < 0.01) in TL in comparison 
with the scopolamine control group. However, Brassica 
oleracea at the dose levels 100 and 200 mg/kg showed a 
decrease in the TL, which is comparable to that shown by 
Piracetam (P < 0.01) [Table 1] 
 
 
Table 1: Effect of the extract of Brassica oleracea on transfer latency (Elevated Plus Maze paradigm) in scopolamine-
induced amnesia in rats 
Treatment Groups TL on acquisition day (sec) TL on retention day(sec) 
7 day 14 day 7 day 14 day 
Vehicle control 94.17±14.96 42.83±5.80 54.33±8.75 23.93±4.11 
Scopolamine hydrobromide 147.77±10.2 114.5±11.13 125.13±19.23 117.83±26.23 
Brassica oleracea (100)+ Scopolamine (0.4) 61.17±7.48 32.18±7.75 44.26±8.17 12.24±2.12 
Brassica oleracea (200)+ Scopolamine (0.4) 53.5±6.65 24.71±3.05 34.27±5.61 13.53±2.02 
Piracetam(120)+ Scopolamine (0.4) 52.17±9.81 23.89±3.61 32.81±1.71 11.75±0.30 
Values are expressed as mean ± SEM at n=6; one way ANOVA followed by Dunnett’s Test 
 
Passive shock avoidance paradigm: The scopolamine 
hydrobromide (0.4 mg / kg i.p.) reduced SDL in AT and RT 
training, indicating a deterioration of memory. There is a 
slight increase in SDL after administration of Brassica 
oleracea (100 and 200 mg / kg po) for 7 days compared to 
the scopolamine control group on AT and RT, indicating an 
improvement in learning and rat's memory. It was found 
that Brassica oleracea (100 and 200 mg / kg) significantly 
reduced (P <0.05) SDL in RT compared to scopolamine 
control after 14 days of administration [Table 2] 
 
Table 2: Effect of the paste of Brassica oleracea on step-down latency (passive avoidance paradigm) in scopolamine-
induced amnesia in rats 
Treatment Groups SDL on acquisition day (sec) SDL on retention day(sec) 
7 day 14 day 7 day 14 day 
Vehicle control 2.72±0.61 1.84±0.44 3.37±0.69 2.56±0.62 
Scopolamine hydrobromide 2.53±0.27 1.19±0.17 1.40±0.78 1.63±0.31 
Brassica oleracea(100)+Scopolamine (0.4) 3.69±1.11 3.14±0.52 4.15±0.75 5.84±1.45 
Brassica oleracea (200)+ Scopolamine (0.4) 3.88±0.76 3.40±0.65 5.29±1.41 6.59±1.54 
Piracetam(120)+ Scopolamine (1) 4.54±0.78 3.91±0.52 5.77±1.05 6.80±1.79 
Values are expressed as mean ± SEM at n=6; one way ANOVA followed by Dunnett’s Test  
 
Biochemical estimation 
AChE levels, which is considered an indicator of inhibition of 
AChE activity in the brain of rat after 7 days of treatment. 
However, in 14 days of treatment, Piracetam (120 mg / kg 
po) and Brassica oleracea (100 and 200 mg / kg po) 
significantly reduced (P <0.01) AChE levels, which is 
considered an indicator of inhibition of the activity of AChE  
[Table 3]. 
 
Table 3: Effect of the extract of Brassica oleracea on AChE Inhibition Activity 
Treatments (mg/kg) AChE concentrated 
(μMol/minute/g of tissue) 
Inhibition of AChE 
activity (%) 
Control 6.742±0.19  
Scopolamine hydrobromide 12.39±0.35  
Brassica oleracea (100)+Scopolamine (0.4) 6.023±0.37 51.38 
Brassica oleracea (200)+Scopolamine (0.4) 5.207±0.29 57.97 
Piracetam(120)+ Scopolamine hydrobromide(0.4) 4.962±0.26 59.09 
Values are expressed as mean ± SEM at n=6; one way ANOVA followed by Dunnett’s Test 
 
DISCUSSIONS 
Alzheimer's disease is a neurogenerative disorder associated 
with a decrease in cognitive abilities. [12]. Despite high 
prevalence of AD, the allopathic system of medicine could not 
provide a satisfactory medicine with minimal side effect. 
Therefore, this study focuses on the searching of the memory 
enhancing activity of the Brassica oleracea extract in 
scopolamine induced amnesic rat model. This study suggests 
that vegetable such as Brassica oleracea can possess 
cognitive enhancing activity in view of its facilitating effect 
on the retention of spatial memory in the scopolamine 
induced amnesia . There is a decrease in TL, that is, rats were 
able to locate the dark area immediately after exposure to 
the open arm in the EPM paradigm, which is an indicator of 
cognitive improvement. [13] 
In the case of the passive avoidance paradigm, SDL is 
increased with the  Brassica oleracea extract. This suggests 
that the animal retains the memory of the discharge once it 
has entered the area without discharge. The long-term 
administration of Brassica oleracea extract (14-day 
administration) showed a pronounced effect on the reversal 
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of scopolamine induced amnesia  in the case of the passive 
avoidance paradigm compared to the 7-day administration. 
It has been investigated and found that cholinergic neuronal 
systems play an important role in the cognitive deficits 
associated with AD, aging and neurodegenerative diseases. 
[14] In our study, Piracetam (120 mg / kg p.o.) and 200mg/kg 
Brassica oleracea extract significantly reduced AChE activity, 
indicating the stimulatory actions of these drugs in the 
cholinergic system. Hence, memory improving effect of the 
Brassica oleracea can be attributed to its anti CHE activity. [15] 
Thus, it can be used to delay the onset and reduces the 
severity of Alzheimer's disease. However, further researches 
should be carried out to explore the possible involvement of 
other neurotransmitters such as glutamate, GABA and 
catecholamine, in memory and learning. [16] 
CONCLUSION 
In the present study, we observed that Brassica oleracea 
reduced elevated acetylcholine (ACh) levels in the brain 
which ultimately, improved memory (spatial and avoidance) 
of rats when its extract administered to rats for 7 days and 
14 days, respectively. In light of the above, it may be worth 
exploring the potential of this plant in the management of 
cognitive dysfunction. 
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